Kotani et al., “Improved methods of retroviral vector transduction and production for gene therapy,” Human Gene Therapy, 5:19-28, 1994. |
Lueckel et al., “Formulations of sugars with amino acids or mannitol—influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate,” Pharm. Dev. Technol., 3:326-336, 1998. |
Mori et al., “Frequent somatic mutation of the MTSl/CDK4I (Multiple Tumor suppressor/Cyclin dependent Kinase 4 Inhibitor) gene in esophageal squamous cell carcinoma,” Cancer Res., 54:3396-3397, 1994. |
Nobori et al., “Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers,” Nature, 368:753-756, 1995. |
Perales et al., “Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake,” Proc. Natl. Acad. Sci. USA, 91:4086-4090, 1994. |
Racher et al., “Culture of 293 cells in different culture systems: cell growth and recombinant adenovirus production,” Biotechnology Techniques, 9:169-174, 1995. |
Sagrera et al., “Study of the influence of salt concentration on Newcastle disease virus matrix protein aggregation,” Biochem. Mol. Biol. Int., 46:429-435, 1998. |
Serrano et al., “Inhibition of ras-induced proliferation and cellular transformation by p16INK4,” Science, 267:249-252, 1995. |
Vanlandschoot et al., “pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin,” Arch. Virol., 143:227-239, 1998. |
Vossen and Fried, “Sequestration stabilizes lac repressor-DNA complexes during gel electrophoresis,” Anal. Biochem., 245:85-92, 1997. |
Weinberg, “Tumor suppressor genes,” Science, 254:1138-1146, 1991. |
Wu and Wu, “Liver-directed gene,” Adv. Drug Delivery Rev., 12:159-167, 1993. |
Co-pending patent application U. S. Ser. No.: 08/975,519. |
Arap et al., “Replacement of the p16/CDKN2 gene suppresses human glioma cell growth,” Cancer Res., 55:1351-1354, 1995. |
Caldas et al., “Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma,” Nat. Genet., 8:27-32, 1994. |
Carver et al., “Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep,” Biotechnology NY, 11:1263-1270, 1993. |
Cheng et al., “p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma,” Cancer Res., 54:5547-5551, 1994. |
Cheung et al., “Structure and function of C-CAM1,” J. Biol. Chem., 268:24303-24310, 1993. |
Corveleyn and Remon, “Maltodextrins as lyoprotectants in the lyophilization of a model protein, LDH,” Pharm. Res., 13:146-150, 1996. |
Croyle et al., “Factors that influence stability of recombinant adenoviral preparations for human gene therapy,” Pharm. Dev. Technol., 3(3):373-383, 1998. |
Ferkol et al., “Regulation of the phosphoenolpyruvate carboxykinase/human factor IX gene introduced into the livers of adult rats by receptor-mediated gene transfer,” FASEB J., 7:1081-1091, 1993. |
Fried and Bromberg, “Factors that affect the stability of protein-DNA complexes during gel electrophoresis,” Electrophoresis, 18:6-11, 1997. |
Hall et al., “Stabilizing effect of sucrose against irreversible denaturation of rabbit muscle lactate dehydrogenase,” Biophys. Chem., 57:47-54, 1995. |
Herman et al., “The effect of bulking agent on the solid-state stability of freeze-dried methylprednisolone sodium succinate,” Pharm. Res., 11:1467-1473, 1994. |
Hollestein et al., “p53 mutations in human cancers,” Science, 253:49-53 1991. |
Hussussian et al., “Germline p16 mutations in familial melanoma,” Nature Genetics, 15-21, 1994. |
Kamb et al., “A cell cycle regulator potentially involved in genesis of many tumor types,” Science, 2674:436-440, 1994. |
Kato et al., “Expression of Hepatitis B virus surface antigen in adult rat liver,” J. Biol. Chem., 266:3361-3364, 1991. |